Search results (219)
« Back to NewsStudy finds methaemoglobin levels could predict malaria recurrence
26 November 2024
A new study has found methaemoglobin levels during treatment for vivax malaria could be used to predict whether a patient would have recurrent malaria.
MODRA Workshop 2 empowers next generation of researchers
19 November 2024
The MORU-OUCRU Discovery Research Academy (MODRA) Workshop 2 was recently held in Ho Chi Minh City, Vietnam.
The Medicine Quality Research Group invited to present at the World Health Summit, Berlin, 15th October
6 November 2024
Conferences & meetings MORU Bangkok
Dr Gesa Gnegel and Dr Céline Caillet were invited to present their current work during a session at the World Health Summit. This international forum and leading global health conference brings together stakeholders from politics, science, the private sector, and civil society. The aim of this event that took place in Berlin from the 13th to the 15th of October 2024 is ‘to set the agenda for a healthier future by inspiring innovative solutions for better health and well-being for all’.
Innovative diagnostics, new tools, near-elimination strategies, cross-border collaborations top agenda at malaria elimination joint meeting
1 November 2024
Conferences & meetings MORU Bangkok
From 24-26 Sept, the Asia Pacific Malaria Elimination Network (APMEN) Vivax Working Group (VxWG) and Surveillance & Response Working Group (SRWG) held their 2024 Joint Annual Meeting in Kuching, Malaysia. Co-organized by SRWG and VxWG host institutions MORU and Medicines for Malaria Venture (MMV), the event took place immediately following the 2024 International Congress for Tropical Medicine and Malaria (ICTMM).
Dr Claire Chewapreecha wins Nature Award for Inspiring Women in Science
1 November 2024
Awards & Appointments MORU Bangkok
Dr Chewapreecha, a Wellcome International Intermediate Fellow and computational biologist at NDM's Mahidol-Oxford Tropical Medicine Research Unit, has been announced as the Individual Winner at this year’s Inspiring Women in Science Awards hosted by Nature and The Estée Lauder Companies. She was honoured at a ceremony in London on 31 October.
Experts gather to discuss medicine quality research
1 November 2024
Conferences & meetings MORU Bangkok
Experts from across Europe joined forces to discuss research on substandard and falsified medical products and how to translate the evidence into policy and implementation. Over forty participants from various countries around the world, all based in Europe, including the UK, Sweden, France, Germany and Belgium, joined the in-person informal event at the Richard Doll Building, in Oxford, on the 24th of October.
Lorenz von Seidlein awarded RSTMH medal for outstanding work in tropical health
29 October 2024
Awards & Appointments MORU Bangkok
On 10 Oct in London, the Royal Society for Tropical Medicine and Hygiene (RSTMH) awarded MORU’s Prof Lorenz von Seidlein (centre) the Donald Mackay Medal for outstanding work in tropical health, especially relating to improvements in the health of rural or urban workers in the tropics.
MODRA Workshop Empowers Early-Career Scientists to Secure Competitive Research Grants
7 October 2024
The MORU-OUCRU Discovery Research Academy (MODRA) recently concluded its inaugural workshop in Bangkok. This intensive five-day programme equipped 15 promising postdoctoral researchers with the skills required to complete a high-quality seed proposal.
New study to support WHO guideline changes
2 October 2024
A new study which will help inform World Health Organization guidelines for treating children with Plasmodium vivax malaria has found that giving children higher doses of primaquine substantially reduced recurrences of malaria.
FORESFA collaborators discuss organised crime groups, AI and public health impact of SF medicines at annual meeting
20 September 2024
From 4-6 Sept, nearly 40 Forensic Epidemiology and impact of Substandard and Falsified Antimicrobials (FORESFA) project collaborators from 10 different countries met at Jesus College, Oxford, to share updates and make final year plans.
Hydroxychloroquine provides moderate COVID-19 prevention, large clinical trial shows
12 September 2024
Four years after being derailed by scientific fraud and politicised science in the first year of the pandemic, COPCOV, the world’s largest COVID-19 chemoprevention study, finally published results today that showed that hydroxychloroquine (HCQ) does have a moderate benefit in preventing COVID-19.
MORU researchers awarded full Oxford professorships
3 September 2024
Awards & Appointments MORU Bangkok
We are delighted to announce that four MORU Tropical Health Network researchers were among 10 NDM researchers recently awarded the title of Professor, in recognition of their research achievements, and contribution to teaching and to the general work of the Nuffield Department of Medicine, University of Oxford, in the most recent recognition of distinction process.
Scientists develop new method to detect fake vaccines
3 September 2024
A team from the University of Oxford and MORU have developed a first of its kind mass spectrometry method for vaccine authenticity screening using machine learning. The method repurposes clinical mass spectrometers already present in hospitals worldwide, making the approach feasible for global supply chain monitoring. The discovery offers an effective solution to the rise in substandard and counterfeit vaccines threatening public health.
Visit MalariaWorld
24 July 2024
MORU Bangkok Public Engagement SMRU
The Malariaworld exhibition was developed in conjunction with World Malaria Day 2024 to raise awareness of malaria and malaria research, and to highlight some of our contributions to malaria research. You can now visit our virtual exhibition!
Immediate policy changes urgently needed as drug-resistant malaria spreads in East Africa
18 July 2024
The efficacy of artemisinin derivatives, the cornerstone of current treatments for malaria, is being compromised in Africa where over 1,000 children are estimated to die each day from the disease. The spread of artemisinin-resistant malaria parasites across East Africa and beyond could result in millions more deaths without immediate health policy changes, warn experts in a paper published in Science.
The MORU – OUCRU Discovery Research Academy Announces its First Cohort
18 July 2024
The MORU – OUCRU Discovery Research Academy (MODRA) is thrilled to announce the selection of its first cohort of the programme. The MORU – OUCRU Discovery Research Academy (MODRA), funded by Wellcome, is a collaborative initiative by the Oxford University Clinical Research Unit (OUCRU) and the Madihol Oxford Tropical Medicine Research Unit (MORU) to nurture the next generation of scientific leaders in low- and middle-income (LMICs) countries of South Asia.
Study details major global impact of herpes infections
4 July 2024
Genital herpes infections and their related complications lead to billions of dollars in health care expenditures and productivity losses globally, say researchers who calculated the first-ever global estimates of the economic costs of these conditions.
PLATCOV researchers find dramatic acceleration of SARS CoV2 viral clearance rates since Sept 2021
29 May 2024
Running continuously since Sept 2021, the PLATCOV trial has randomised over 1700 patients presenting with COVID19 infections. Work by PLATCOV’s Dr Phrutsamon Wongnak published in the Lancet Infectious Diseases has shown that rates of oropharyngeal viral clearance have accelerated dramatically since the trial started: A SARS CoV2 viral clearance half-life in untreated patients of around 16 hours In Sept 2021 had reduced to around 9 hours by Oct 2023. The results highlight the importance of pharmacometric platform trials like PLATCOV, so that we are prepared for the next pandemic.
Pan made Associate Professor at Oxford
17 May 2024
Awards & Appointments MORU Bangkok
In April 2024, the Head of MAEMOD, Wirichada (Pan) Pan-ngum was awarded the title of Associate Professor at the University of Oxford in recognition of her contributions to research, teaching and administration/citizenship at Oxford and beyond. Please join us in extending your heartiest congratulations to Pan for this significant honour and recognition of academic achievement. Well done, Pan!
Experts join forces to improve screening devices to detect substandard and falsified medicines
30 April 2024
Experts from across the globe joined forces to discuss how screening technologies can be improved so they can be more widely used to detect substandard and falsified medical products.
Significant global variation in national COVID-19 treatment guidelines
23 April 2024
A new study, led by researchers at the Infectious Diseases Data Observatory (IDDO) and the Mahidol Oxford Tropical Medicine Research Unit (MORU) at NDM, found that a large number of national guidelines recommend at least one treatment proven not to work.
Interview with Diagnostics in Tropical and Infectious Diseases(DiTi) award recipient Dr Christopher Chew
17 April 2024
Global Health research at the University of Oxford and its partners is broad reaching, bringing significant impact across all academic disciplines of medicine, the physical and life sciences, social sciences and humanities. The Diagnostics in Tropical and Infectious Disease (DiTi) award, run by the Translational Research Office, aims to strengthen the long-term partnership between Oxford University and Mahidol University by establishing partnerships and supporting collaborative projects to develop diagnostic devices for tropical and infectious diseases, with the goal of driving more translational research initiatives in global health. Read this interview from award winner Dr Chris Chew.
Geospatial modelling study highlights Indian regions with treatment-resistant malaria parasites
16 April 2024
An updated systematic search and review of published information from over 4,000 malaria samples has identified areas in central, eastern and north-eastern India where treatment-resistant malaria parasites could be more prevalent.
Rapid diagnostic test offers cost-effective solutions for non-malarial febrile illness
10 April 2024
New research by the Mahidol Oxford Tropical Medicine Research Unit, explores the potential benefits of a presumptive lateral flow rapid diagnostic test in managing acute non-malarial febrile illness (NMFI) patient care in rural areas of Southeast Asia.
New rapid test for melioidosis could diagnose patients in hours, and help save lives across Asia and the tropics
5 April 2024
Researchers have found that a new test using a CRISPR-Cas12a system (CRISPR-BP34) diagnosed patients with melioidosis, an often-fatal tropical disease caused by the bacteria Burkholderia pseudomallei, within hours, rather than days as in current bacterial culture methods, so patients could receive the correct, life-saving antibiotics faster.
Children with acute malnutrition and malaria: the double burden that increases risk of treatment failure
13 March 2024
An analysis of over 11,000 falciparum malaria individual patient data sets has found that acutely malnourished children have a higher risk of reinfections and treatment failures, even when treated with recommended doses of artemisinin-based combination therapies, currently the best malaria treatment available. The malaria parasite clearance was also likely to be longer in these children.
New study uses isotope ratio mass spectrometry to analyse origins of falsified antimalarials
20 February 2024
New work from the Medicine Quality Group at IDDO and MORU pilots the use of stable isotope mass spectrometry to estimate where falsified antimalarials and their components come from. The study, published in Scientific Reports, is a collaboration between the Medicine Quality Research Group, LOMWRU, and MORU Bangkok, working with stable isotope scientists in Utah, USA.
Repurposed tests can detect falsified vaccines, study finds
16 February 2024
Researchers have found that widely available rapid diagnostic tests (RDTs), typically used for common infections, can be repurposed to detect substandard and falsified (SF) vaccines, a significant but overlooked issue in global public health. Preliminary data suggests RDTs could be utilized by international organizations and regulators to screen vaccine supply chains for falsified products. This innovative approach addresses the urgent need for affordable tools to combat the threat of SF vaccines.
GRAM study reveals rising antimicrobial resistance in enteric fever across 75 countries, affecting millions
15 February 2024
Findings reveal resistance patterns for a priority pathogen--also known as typhoid fever--with high mortality and morbidity in resource-constrained settings
Book chapter highlights issues of poor-quality medical products during the global pandemic
5 February 2024
MORU' and IDDO’s Medicine Quality Research Group (MQRG) have written a chapter in a new book which examines the global issue of substandard and falsified medical products.
Anomaly detection improves real-time dengue surveillance in Thailand
23 January 2024
A recent study by the Mahidol-Oxford Tropical Medicine Research Unit (MORU) at NDM outlined a highly effective method for dengue surveillance. The researchers improved risk detection in real time by combining space-time modelling and anomaly detection. This will help in making dengue prevention more effective not only in Thailand but also in other regions with similar challenges.
High dose oral favipiravir does not accelerate COVID-19 viral clearance, Oxford researchers find
19 January 2024
Giving high oral doses of the anti-influenza drug Favipiravir to adults with early symptomatic COVID-19 treatment did not accelerate viral clearance, say researchers in a study published in BMC Infectious Diseases. In fact, there was no difference in the rate of viral clearance between patients given favipiravir and patients receiving no study drug.
Neglected disease raises new ethical questions: Nipah virus control and research
10 January 2024
Although Nipah virus gets increasing attention in epidemic preparedness, there has been almost no bioethical work on the epidemiology, prevention, and treatment. Further work on public health ethics should address communication about the modes of transmission, surveillance, measures during epidemics, and social or religious norms, as well as potential vaccine trials and the different local contexts where trials may occur, and the use of unproven therapeutics during outbreaks. Further bioethics work may help to ensure that research and public health interventions for Nipah virus disease are ethically acceptable and more likely to be effective.
Early warning systems for malaria outbreaks in Thailand
9 January 2024
In a recent study, NDM’s Mahidol Oxford Tropical Medicine Research Unit (MORU) researchers introduced an anomaly detection system, as an early warning mechanism for potential malaria outbreaks in countries like Thailand.
Placing community health workers in remote areas key to eliminating Falciparum malaria in Myanmar and GMS
22 December 2023
Medical Action Myanmar successfully eliminated falciparum malaria in Eastern Myanmar within six years, employing 172 community health workers for early diagnosis and treatment. Their approach, integrating basic health services with malaria care, led to a rapid reduction in both falciparum and vivax malaria cases. This cost-effective strategy challenges traditional, labor-intensive methods, emphasizing the importance of community health workers in achieving malaria elimination in challenging, remote areas.
New MORU-led study to test a single pill to fight drug-resistant malaria in Africa and Asia
14 December 2023
To boost the fight against drug-resistant malaria parasites now emerging in Africa, researchers will study the safety and efficacy of a fixed-dose combination (FDC) containing three antimalarial drugs currently given to patients separately in a triple artemisinin-based combination therapy (TACT) cocktail.
Antimicrobial resistance is a silent killer that leads to 5 million deaths a year. Solutions must include the poor
19 November 2023
AMR has been linked to close to 5 million deaths annually. We need urgent global action to counter antimicrobial resistance, but current efforts focus on solutions developed in high-income settings. If we want people to become less dependent on antibiotics, we must address the factors that create dependency on antibiotics in the first place. The solution we are working towards is fair and inclusive; it respects people and their traditions while also benefiting human health, animal welfare and the natural environment.
Just by shining a light into an unopened vial, handheld device can quickly detect falsified COVID-19 vaccines
10 November 2023
Handheld Spatially Offset Raman Spectroscopy (SORS) devices offer new hope for easily detecting falsified COVID-19 vaccines — even if the vaccine vials are unopened, say researchers in a paper published in Vaccine on 20 Oct 2023
Estimating hospital-acquired SARS-CoV-2 infections in England
24 October 2023
An estimated 95,000–167,000 inpatients at English National Health Service (NHS) hospitals caught SARS-CoV-2 while in hospital during England’s ‘second wave’ of COVID-19, between June 2020 and March 2021, reports a study in Nature. The findings reveal the scale of hospital transmissions and highlight contributing factors, such as a limited number of single rooms.
RSTMH recognises Prof Arjen Dondorp’s contributions to significantly improving health in the tropics
24 October 2023
Awards & Appointments MORU Bangkok
We were delighted to hear that MORU Deputy Director of MORU and Head of Malaria & Critical Illness, Prof Arjen Dondorp, has been awarded the highly prestigious 2023 George Macdonald Medal!! This medal recognises outstanding individual contribution for conducting research leading to significant improvements in health in the tropics. It is a joint award from the London School of Hygiene & Tropical Medicine (LSHTM) and the Royal Society of Tropical Medicine & Hygiene (RSTMH).